Document:

License Agreement Michigan File 1387 Technology

 EXHIBIT 10.13 
  
 LICENSE AGREEMENT 
 MICHIGAN FILE 1387 TECHNOLOGY 
  
 This is an
Agreement between IntraLase Corp., a corporation incorporated in the State of Delaware, with offices located at 245 North Main Street, Ann Arbor, Michigan 48104 (“LICENSEE”), and the Regents of the University of Michigan, a constitutional
corporation of the State of Michigan (“MICHIGAN”). This Agreement is effective as of the date executed by both LICENSEE and MICHIGAN (the “Effective Date”). LICENSEE and MICHIGAN agree as follows: 
  

	1.	 	BACKGROUND 

  

	 	1.1	 	MICHIGAN has developed rights, including potential patent rights, in a compact pulse stretcher-compressor using a single transmission grating, invented by Xinbing Liu, Alan Braun
and Christopher Horvath, as identified and described in the University of Michigan Technology Management Office File #1387 (hereafter, “The #1387 Invention”). 

  

	 	1.2	 	LICENSEE desires to obtain, and MICHIGAN, consistent with its mission of education and research, desires to grant a license of The #1387 Invention on the terms and conditions listed
below. 

  

	2.	 	TERMS AND CONDITIONS FOR LICENSE 

  
 The license from MICHIGAN to LICENSEE for The #1387 Invention shall be added to and be incorporated in the license agreement existing between MICHIGAN and
LICENSEE effective December 16, 1997, covering MICHIGAN’s Technology Management Office File #939, as well as other potential technologies (hereafter, “The #939 Agreement”), with the following revisions to The #939 Agreement:

  

	 	2.1	 	The following shall be added to the definition in Paragraph 2.12: TECHNOLOGY shall also include The #1387 Invention. 

  

	 	2.2	 	The following revisions shall be made to the definition in Paragraph 2.1: 

  

	 	(a)	 	The orignal definition of Field of Use shall be designated as subparagraph (a); and 

  

	 	(b)	 	Subparagraph (b) shall be added: (b) The Field of Use for The #1387 Invention shall be for any and all uses. 

  

	 	2.3	 	Paragraph 9.1 shall be revised to read as follows: “LICENSEE acknowledges MICHIGAN’s ownership interest in all Licensed Patents as defined in Paragraph 2.3(a) above and in
The #1387 Invention.” 

  

	 	2.4	 	 Note that the intention is that, for The #1387 Inventon, IntraLase will reimburse all (100%) of the patent expenses discussed in Section 10. This should be
automatic by including The #1387 Invention in the definition of TECHNOLOGY, and not including it in Exhibit B. See the third paragraph under Paragraph 10.4 of The #939 Agreement (The Paragraph which starts with the words “Thereafter
MICHIGAN”). Any and all patents or patent applications covering The 

  

 1 

	 	 
#1387 Invention are intended to be included in “other Licensed Patents” in this paragraph. Note also that the obligation of LICENSEE relates only
to reasonable and necessary out-of-pocket expenses, as already specified in the second paragraph under Subsection 10.4 of The 939 Agreement. 

  

	 	2.5	 	In Section 20, in the address for the notices to MICHIGAN add that the there shall be a reference to File No. 1387, as well as to File No. 939. 

  

	 	2.6	 	In Paragraph 4.3(i), the royalties shall remain the same as specified in The 939 Agreement; and in Paragraph 4.3(ii) the royalty shall remain the same as specified in The 939
Agreement. 

  

	 	2.7	 	In Paragraph 4.6, the annual license maintenance fees shall remain the same as in The 939 Agreement. 

  

	3.	 	REGENTAL APPROVAL. 

  
 This Agreement is subject to approval by a two thirds majority vote of the Regents of the University of Michigan. 
  
 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement in duplicate originals by
their duly authorized officers or representatives. 
  

									
	 FOR INTRALASE, CORP.
	 	 	 	FOR THE REGENTS OF THE UNIVERSITY OF MICHIGAN
					
	By:	 	 /s/    Thomas Porter        

	 	 	 	By:	 	 /s/    Marvin G. Parnes        

	 	 	 (authorized representative)
	 	 	 	 	 	 (authorized representative)

			
	 Typed Name:  Thomas
Porter                    
	 	 	 	Typed Name  MARVIN G.
PARNES                    
	 Title:  Treasurer                                  
      
	 	 	 	Title:  Associate Vice President for Research Interim Director, Technology Management Officer
			
	 Date: 8-10-98
	 	 	 	Date: 7-22-98

  

 2License Agreement Michigan File 1509 Technology

 EXHIBIT 10.14 
  
 LICENSE AGREEMENT 
 MICHIGAN FILE 1509 TECHNOLOGY 
  
 This is an Agreement
between IntraLase Corp., a corporation incorporated in the State of Delaware, with offices located at 245 North Main Street, Ann Arbor, Michigan 48104 (“LICENSEE”), and the Regents of the University of Michigan, a constitutional
corporation of the State of Michigan (“MICHIGAN”). This Agreement is effective as of the date executed by both LICENSEE and MICHIGAN (the “Effective Date”). LICENSEE and MICHIGAN agree as follows: 
  
 1. BACKGROUND. 
  
 1.1 MICHIGAN has developed rights, including potential patent rights, in a
method for transcleral and transconjunctival laser photodisruption for glaucoma surgery, invented by Tibor Juhasz, Zachary Sacks, Gerard Mourou, and Ron Kurtz, as identified and described in the University of Michigan Technology Management Office
File #1509 (hereafter, “The #1509 Invention”). 
  
 1.2
LICENSEE desires to obtain, and MICHIGAN, consistent with its mission of education and research, desires to grant a license of The #1509 Invention on the terms and conditions listed below. 
  
 2. TERMS AND CONDITIONS FOR LICENSE. 
  
 The license from MICHIGAN to LICENSEE for The #1509 Invention shall be added
to and be incorporated in the license agreement existing between MICHIGAN and LICENSEE effective December 16, 1997, covering MICHIGAN’s Technology Management Office File #939, as well as other potential technologies (hereafter, “The #939
Agreement”), with the following revisions to The #939 Agreement: 
  
 2.1 The following shall be added to the definition in Paragraph 2.12: TECHNOLOGY shall also include The #1509 Invention. 
  
 2.2 The following revisions shall be made to the definition in Paragraph 2.1: 
  
 (a) The original definition of Field of Use shall be designated as subparagraph (a); and 
  
 (b) Subparagraph (c) shall be added: (c) The Field of Use for The #1509
Invention shall be for any and all uses. 
  
 2.3 Paragraph 9.1
shall be revised to read as follows: “LICENSEE acknowledges MICHIGAN’s ownership interest in all Licensed Patents as defined in Paragraph 2.3(a) above and in The #1509 Invention.” 
  
 2.4 Note that the intention is that, for The #1509 Inventon, IntraLase will
reimburse all (100%) of the patent expenses discussed in Section 10. This should be automatic by including The #1509 Invention in the definition of TECHNOLOGY, and not including it in Exhibit B. See the third paragraph under Paragraph 10.4 of The
#939 Agreement (The Paragraph which starts with the words “Thereafter MICHIGAN”). Any and all patents or patent applications covering The #1509 Invention are intended to be included in “other Licensed Patents” in this 

 paragraph. Note also that the obligation of LICENSEE relates only to reasonable and necessary out-of-pocket expenses, as
already specified in the second paragraph under Subsection 10.4 of The 939 Agreement. 
  
 2.5 In Section 20, in the address for the notices to MICHIGAN add that the there shall be a reference to File No. 1509, as well as to File No. 939. 
  
 2.6 In Paragraph 4.3(i), the royalties shall remain the same as specified in The 939 Agreement; and in Paragraph 4.3(ii) the
royalty shall remain the same as specified in The 939 Agreement. 
  
 2.7 In Paragraph 4.6, the annual license maintenance fees shall remain the same as in The 939 Agreement. 
  
 3. REGENTAL APPROVAL. 
  
 This Agreement is subject to approval by a two thirds majority vote of the Regents of the University of Michigan. 
  
 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement in
duplicate originals by their duly authorized officers or representatives. 
  

									
	 FOR INTRALASE, CORP.
	 	 	 	 FOR THE REGENTS OF THE UNIVERSITY
 OF MICHIGAN

					
	 By:
	 	
	 	 	 	 By:
	 	  

	 	 	 (authorized representative)
	 	 	 	 	 	 (authorized representative)

			
	 Typed
Name                                       
                                      
 
	 	 	 	 Typed
Name                                       
                                      
 

			
	 Title                                     
                                        
                 
	 	 	 	 Title                                     
                                        
                 

			
	 Date                                      
                                        
                
	 	 	 	 Date                                      
                                        
                

  

 2Amendment to License Agreement Michigan File 1509 Technology

 EXHIBIT 10.15 
  
 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote such
omissions. 
  
 AMENDMENT TO “LICENSE AGREEMENT

 MICHIGAN FILE 1509 TECHNOLOGY” 
 BETWEEN 
 THE REGENTS OF THE UNIVERSITY OF MICHIGAN 
 AND INTRALASE CORP. 
  
 This Amendment to “License Agreement Michigan File 1509 Technology” (hereinafter “1509 License Agreement”) is made and entered into as
of this 23rd day of January 2003 (“Effective Date”), by and between the Regents of the University of Michigan, a constitutional corporation of the State of Michigan (“Michigan”), and IntraLase Corp., a Delaware corporation
(“Licensee”). 
  
 WHEREAS, Michigan and Licensee entered
into a “License Agreement Michigan File 939 Technology” (hereinafter “939 License Agreement”) effective as of December 16, 1997, pursuant to which Michigan agreed to license to Licensee certain patents, patent applications, and
technology as described in Michigan’s Office of Technology Transfer File No. 939 relating to the use of lasers for human health and human cosmetic applications; 
  
 WHEREAS, Michigan and Licensee entered into the 1509 License Agreement effective as of August 10, 1998, pursuant to which
Michigan agreed to include in the 939 License Agreement a license to certain patents, patent applications, and technology as described in Michigan’s Office of Technology Transfer File No. 1509 relating to the use of lasers for any and all uses;

  
 WHEREAS, Michigan and Licensee desire to modify certain
provisions of the 939 License Agreement and the 1509 License Agreement as provided herein; 
  
 NOW THEREFORE, for the consideration set forth below and other good and valuable consideration, the receipt and sufficiency of which are acknowledged by both parties, Michigan and Licensee hereby agree as follows:

  
 1. Paragraph 2.12 of the 939 License Agreement and Article 2
of the 1509 License Agreement shall be amended to exclude U.S. patent application *** from the definition of TECHNOLOGY, except to the extent that any disclosed subject matter is otherwise included within the definition of TECHNOLOGY. 
  
 2. Paragraph 2.3 of the 939 License Agreement shall be amended to exclude
U.S. patent application *** from the definition of Licensed Patents. Licensee shall have no obligation to reimburse Michigan’s patent expenses with respect to U.S. patent application *** incurred after the Effective Date of this Amendment.

  
 3. This Amendment shall not affect the rights granted to
Licensee under U.S. Patent No. 6,146,375. 
  
 4. All other
provisions of the 939 License Agreement and the 1509 License Agreement shall remain in full force and effect. 
  
 5. In the event a conflict arises with respect to the interpretation of this Amendment, the provisions of the 939 License Agreement and 1509 License
Agreement shall control. 

	***	Material has been omitted pursuant to a request for confidential treatment. 

 6. This Amendment, the 939 License Agreement, and the 1509 License Agreement contain the entire
understanding of the parties with respect to the subject matter contained herein. 
  
 7. This Amendment shall not be altered, modified, or amended except in a writing, said writing being executed by authorized officials of both parties hereto. 
  
 IN WITNESS WHEREOF, each of the parties has caused this Amendment to be
executed in duplicate originals by its duly authorized representative. 
  

									
	THE REGENTS OF THE UNIVERSITY OF MICHIGAN	 	 	 	INTRALASE, CORP.
					
	 By:
	 	
	 	 	 	 By:
	 	  

	 	 	 Kenneth J. Nisbet
 Executive Director
 UM Technology Transfer
	 	 	 	 Name:                                     
                                        
             
  
 Title:                                     
                                        
               

  

 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00067-of-00352.parquet"}]]